Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells

Biochemical Pharmacology

Volumn 70, Issue 9, 2005, Pages 1389-1397

  Shinkai, Koji ^a   Yoshimura, Reiji ^a   Toyohira, Yumiko ^a   Ueno, Susumu ^a   Tsutsui, Masato ^a   Nakamura, Jun ^a   Yanagihara, Nobuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Adrenal medullary cells; Milnacipran; Norepinephrine transporter; Serotonin norepinephrine reuptake inhibitor; Up regulation

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLOHEXIMIDE; DACTINOMYCIN; DESIPRAMINE; DNA DIRECTED RNA POLYMERASE; MESSENGER RNA; MILNACIPRAN; NORADRENALIN; NORADRENALIN TRANSPORTER; PAROXETINE; PROTEIN; RIBOSOME PROTEIN; TRITIUM;

ADRENAL CELL; ADRENAL MEDULLA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL CULTURE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG UPTAKE; INHIBITION KINETICS; LIGAND BINDING; LONG TERM EXPOSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN SYNTHESIS; UPREGULATION;

ADRENAL MEDULLA; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CATTLE; CELLS, CULTURED; CYCLOHEXIMIDE; CYCLOPROPANES; DACTINOMYCIN; DESIPRAMINE; GENE EXPRESSION REGULATION; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PAROXETINE; RNA, MESSENGER; UP-REGULATION;

EID: 25644438328     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.07.031     Document Type: Article

References (36)

1. S.G. Amara, and M.J. Kuhar Neurotransmitter transporters: recent progress Annu Rev Neurosci 16 1993 73 93
2. E.L. Barker, and R.D. Blakely Norepinephrine and serotonin transporters F.E. Bloom DJ. Kupfer Molecular targets of antidepressant drugs, psychopharmacology: fourth generation of progress 1995 Raven Press New York 321 333
3. 3H-desipramine to the neuronal noradrenaline carrier of rat phaeochromocytoma cells (PC-12 cells) Naunyn-Schmiedeberg's Arch Pharmacol 334 1986 403 411
4. L.L. Iversen, and E.A. Kravitz Sodium dependence of transmitter uptake at adrenergic nerve terminals Mol Pharmacol 2 1966 360 362
5. C. Moret, M. Charveron, J.P. Finberg, J.P. Couzinier, and M. Briley Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2- aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug Neuropharmacol 24 1985 1211 1219
6. A. Stenger, J.P. Couzinier, and M. Briley Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant Psychopharmacol (Berl) 91 1987 147 153
7. K.L. Dechant, S.P. Clissold, and Paroxetine A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness Drugs 41 1991 225 253
8. M.J. Owens, D.L. Knight, and C.B. Nemeroff Paroxetine binding to the rat norepinephrine transporter in vivo Biol Psychiatry 47 2000 842 845
9. T. Pacholczyk, R.D. Blakely, and S.G. Amara Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter Nature 350 1991 350 354
10. B. Lingen, M. Brüss, and H. Bönisch Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter FEBS Lett 342 1994 235 238
11. H. Bönisch, and M. Brüss The noradrenaline transporter of the neuronal plasma membrane Ann N Y Acad Sci 733 1994 193 202
12. K. Hara, N. Yanagihara, K. Minami, H. Hirano, T. Sata, and A. Shigematsu Dual effects of intravenous anesthetics on the function of norepinephrine transporters Anesthesiology 93 2000 1329 1335
13. K. Hara, K. Minami, S. Ueno, Y. Toyohira, M. Tsutsui, and A. Shigematsu Up-regulation of noradrenaline transporter in response to prolonged exposure to ketamine Naunyn-Schmiedeberg's Arch Pharmacol 365 2002 406 412
14. R. Yoshimura, N. Yanagihara, K. Hara, T. Terao, J. Nakamura, and S. Ueno Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells Psychopharmacology 149 2000 17 23
15. R. Yoshimura, N. Yanagihara, K. Hara, J. Nakamura, Y. Toyohira, and S. Ueno Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine J Neurochem 77 2001 1018 1026
16. 3H]nisoxetine autoradiography Brain Res 582 1992 208 214
17. 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells Brain Res Bull 49 1999 291 295
18. M.Y. Zhu, and G.A. Ordway Down-regulation of norepinephrine transporters on PC12 cells by transporter inhibitors J Neurochem 68 1997 134 141
19. M.Y. Zhu, R.D. Blakely, S. Apparsundaram, and G.A. Ordway Down-regulation of the human norepinephrine transporter in intact 293-hNET cells exposed to desipramine J Neurochem 70 1998 1547 1555
20. A. Biegon Effect of chronic desipramine treatment on dihydroalprenolol, imipramine, and desipramine binding sites: a quantitative autoradiographic study in the rat brain J Neurochem 47 1986 77 80
21. M.M. Shores, P. Szot, and R.C. Veith Desipramine-induced increase in norepinephrine transporter mRNA is not mediated via alpha 2 receptors Brain Res Mol Brain Res 27 1994 337 341
22. N. Yanagihara, M. Isosaki, T. Ohuchi, and M. Oka Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells FEBS Lett 105 1979 296 298
23. 2+ in cultured bovine adrenal medullary cells J Biol Chem 271 1996 17463 17468
24. Y. Toyohira, N. Yanagihara, K. Minami, S. Ueno, Y. Uezono, and E. Tachikawa Down-regulation of the noradrenaline transporter by interferon-alpha in cultured bovine adrenal medullary cells J Neurochem 70 1998 1441 1447
25. L.D. Jayanthi, S. Ramamoorthy, V.B. Mahesh, F.H. Leibach, and V. Ganapathy Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells J Biol Chem 269 1994 14424 14429
26. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
27. 3H]-desipramine binding site of the bovine adrenomedullary plasma membrane Naunyn-Schmiedeberg's Arch Pharmacol 346 1992 203 207
28. S.L. Eastwood, J. Heffernan, and P.J. Harrison Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes Mol Psychiatry 2 1997 322 329
29. S.N. Vaishnavi, C.B. Nemeroff, S.J. Plott, S.G. Rao, J. Kranzler, and M.J. Owens Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity Biol Psychiatry 55 2004 320 322
30. M.Y. Zhu, S. Shamburger, J. Li, and G.A. Ordway Regulation of the human norepinephrine transporter by cocaine and amphetamine J Pharmacol Exp Ther 295 2000 951 959
31. R.D. Blakely, and A.L. Bauman Biogenic amine transporters: regulation in flux Curr Opin Neurobiol 10 2000 328 336
32. U. Sung, J.L. Jennings, A.J. Link, and R.D. Blakely Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins Biochem Biophys Res Commun 333 2005 671 678
33. S. Benmansour, A.V. Altamirano, D.J. Jones, T.A. Sanchez, G.G. Gould, and M.C. Pardon Regulation of the norepinephrine transporter by chronic administration of antidepressants Biol Psychiatry 55 2004 313 316
34. P. Szot, E.A. Ashliegh, R. Kohen, E. Petrie, D.M. Dorsa, and R. Veith Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment Brain Res 618 1993 308 312
35. C. Puozzo, H. Albin, G. Vincon, D. Deprez, J.M. Raymond, and M. Amouretti Pharmacokinetics of milnacipran in liver impairment Eur J Drug Metab Pharmacokinet 23 1998 273 279
36. C.M. Kaye, R.E. Haddock, P.F. Langley, G. Mellows, T.C. Tasker, and B.D. Zussman A review of the metabolism and pharmacokinetics of paroxetine in man Acta Psychiatr Scand 350 Suppl. 1989 60 75